FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2618294567> ?p ?o ?g. }

• W2618294567 endingPage "166" @default.
• W2618294567 startingPage "162" @default.
• W2618294567 abstract "The developing brains of pediatric patients are highly vulnerable to anesthetic regimen (e.g., lidocaine), potentially causing neurological impairment. Recently, dexmedetomidine (DEX) has been used as an adjunct for sedation, and was shown to exert dose-dependent neuroprotective effects during brain injury. However, the maximum safe dose of DEX is unclear, and its protective effects against lidocaine-related neurotoxicity need to be confirmed. In this study, PC12 and NG108-15 cells were used to estimate safe, non-cytotoxic doses of DEX. We found that 100 and 60 μM are the maximum safe dose of DEX for PC12 and NG108-15 cells, respectively, with no significant cytotoxicity. Lidocaine was found to remarkably inhibit cell vitality, but could be reversed by different doses of DEX, especially its maximum safe dose. Furthermore, the apoptosis induced by lidocaine was also assessed, and 100 and 60 μM DEX showed optimal protective effects in PC12 and NG108-15 cells, respectively. Mechanistically, DEX activated the mitogen-activated protein kinase (MAPK) pathway, impaired caspase-3 expression, and enhanced anti-apoptotic factor Bcl-2 to resist lidocaine-induced apoptosis, indicating that the optimal dose of DEX alleviates lidocaine-induced cytotoxicity and should be considered in clinical application." @default.
• W2618294567 created "2017-06-05" @default.
• W2618294567 creator A5003799076 @default.
• W2618294567 creator A5015197919 @default.
• W2618294567 creator A5017819441 @default.
• W2618294567 creator A5020700981 @default.
• W2618294567 creator A5026948986 @default.
• W2618294567 creator A5042467158 @default.
• W2618294567 creator A5062493663 @default.
• W2618294567 creator A5063327158 @default.
• W2618294567 creator A5090122963 @default.
• W2618294567 date "2017-07-01" @default.
• W2618294567 modified "2023-09-25" @default.
• W2618294567 title "Dexmedetomidine inhibits activation of the MAPK pathway and protects PC12 and NG108-15 cells from lidocaine-induced cytotoxicity at its maximum safe dose" @default.
• W2618294567 cites W1805129498 @default.
• W2618294567 cites W1895508641 @default.
• W2618294567 cites W1965017177 @default.
• W2618294567 cites W1997778988 @default.
• W2618294567 cites W1999485470 @default.
• W2618294567 cites W1999492173 @default.
• W2618294567 cites W2003775890 @default.
• W2618294567 cites W2003918195 @default.
• W2618294567 cites W2010147957 @default.
• W2618294567 cites W2017940022 @default.
• W2618294567 cites W2044424226 @default.
• W2618294567 cites W2048280114 @default.
• W2618294567 cites W2049619891 @default.
• W2618294567 cites W2051805371 @default.
• W2618294567 cites W2054895534 @default.
• W2618294567 cites W2075296319 @default.
• W2618294567 cites W2084891501 @default.
• W2618294567 cites W2111245723 @default.
• W2618294567 cites W2149509906 @default.
• W2618294567 cites W2150572794 @default.
• W2618294567 cites W2178239841 @default.
• W2618294567 cites W2313035513 @default.
• W2618294567 cites W2338117749 @default.
• W2618294567 cites W4245076968 @default.
• W2618294567 doi "https://doi.org/10.1016/j.biopha.2017.04.084" @default.
• W2618294567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28463790" @default.
• W2618294567 hasPublicationYear "2017" @default.
• W2618294567 type Work @default.
• W2618294567 sameAs 2618294567 @default.
• W2618294567 citedByCount "12" @default.
• W2618294567 countsByYear W26182945672018 @default.
• W2618294567 countsByYear W26182945672019 @default.
• W2618294567 countsByYear W26182945672020 @default.
• W2618294567 countsByYear W26182945672021 @default.
• W2618294567 countsByYear W26182945672022 @default.
• W2618294567 countsByYear W26182945672023 @default.
• W2618294567 crossrefType "journal-article" @default.
• W2618294567 hasAuthorship W2618294567A5003799076 @default.
• W2618294567 hasAuthorship W2618294567A5015197919 @default.
• W2618294567 hasAuthorship W2618294567A5017819441 @default.
• W2618294567 hasAuthorship W2618294567A5020700981 @default.
• W2618294567 hasAuthorship W2618294567A5026948986 @default.
• W2618294567 hasAuthorship W2618294567A5042467158 @default.
• W2618294567 hasAuthorship W2618294567A5062493663 @default.
• W2618294567 hasAuthorship W2618294567A5063327158 @default.
• W2618294567 hasAuthorship W2618294567A5090122963 @default.
• W2618294567 hasConcept C109316439 @default.
• W2618294567 hasConcept C126322002 @default.
• W2618294567 hasConcept C126838900 @default.
• W2618294567 hasConcept C149857219 @default.
• W2618294567 hasConcept C184235292 @default.
• W2618294567 hasConcept C185592680 @default.
• W2618294567 hasConcept C190283241 @default.
• W2618294567 hasConcept C202751555 @default.
• W2618294567 hasConcept C25498285 @default.
• W2618294567 hasConcept C2776814716 @default.
• W2618294567 hasConcept C2778162923 @default.
• W2618294567 hasConcept C2779491297 @default.
• W2618294567 hasConcept C2780149897 @default.
• W2618294567 hasConcept C2781302539 @default.
• W2618294567 hasConcept C29730261 @default.
• W2618294567 hasConcept C42219234 @default.
• W2618294567 hasConcept C55493867 @default.
• W2618294567 hasConcept C57074206 @default.
• W2618294567 hasConcept C71924100 @default.
• W2618294567 hasConcept C98274493 @default.
• W2618294567 hasConceptScore W2618294567C109316439 @default.
• W2618294567 hasConceptScore W2618294567C126322002 @default.
• W2618294567 hasConceptScore W2618294567C126838900 @default.
• W2618294567 hasConceptScore W2618294567C149857219 @default.
• W2618294567 hasConceptScore W2618294567C184235292 @default.
• W2618294567 hasConceptScore W2618294567C185592680 @default.
• W2618294567 hasConceptScore W2618294567C190283241 @default.
• W2618294567 hasConceptScore W2618294567C202751555 @default.
• W2618294567 hasConceptScore W2618294567C25498285 @default.
• W2618294567 hasConceptScore W2618294567C2776814716 @default.
• W2618294567 hasConceptScore W2618294567C2778162923 @default.
• W2618294567 hasConceptScore W2618294567C2779491297 @default.
• W2618294567 hasConceptScore W2618294567C2780149897 @default.
• W2618294567 hasConceptScore W2618294567C2781302539 @default.
• W2618294567 hasConceptScore W2618294567C29730261 @default.
• W2618294567 hasConceptScore W2618294567C42219234 @default.
• W2618294567 hasConceptScore W2618294567C55493867 @default.
• W2618294567 hasConceptScore W2618294567C57074206 @default.

• next